May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Loss of FGF2 Retards Proliferation of Epithelial Cells in an Uninjured or a Penetrating Injured Cornea in Mice
Author Affiliations & Notes
  • T. Tanaka
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • S. Saika
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • Y. Ohnishi
    Ophthalmology, Wakayama Medical University, Wakayama, Japan
  • C.–Y. Liu
    Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL
  • M. Azhar
    Molecular Genetics,
    University of Cincinnati Medical Center, Cincinnati, OH
  • T. Doetschman
    Molecular Genetics,
    University of Cincinnati Medical Center, Cincinnati, OH
  • W.W. Kao
    Ophthalmology,
    University of Cincinnati Medical Center, Cincinnati, OH
  • Footnotes
    Commercial Relationships  T. Tanaka, None; S. Saika, None; Y. Ohnishi, None; C. Liu, None; M. Azhar, None; T. Doetschman, None; W.W. Kao, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2118. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Tanaka, S. Saika, Y. Ohnishi, C.–Y. Liu, M. Azhar, T. Doetschman, W.W. Kao; Loss of FGF2 Retards Proliferation of Epithelial Cells in an Uninjured or a Penetrating Injured Cornea in Mice . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2118.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To examine the roles of fibroblast growth factor 2 (FGF2) in regulating proliferation of corneal epithelial cells in vivo and in vitro. Methods: Experimental mice (34 Fgf2+/+ and 42 Fgf2–/–) were under both general and topical anesthesia. A penetrating wound was created with a hypodermic needle in one eye. At days 2, 5, and 10 post–injury the mice were sacrificed following a 2 hr–labeling period with bromo–deoxyuridine (BrdU). The number of BrdU–labeled cells and those positive in TUNEL staining in epithelium was determined. The effects of exogenous FGF2 and an inhibitor of MAP kinase, PD98059, on cell proliferation of SV40–immortalized human corneal epithelial cells (HCECs) were determined. Results: Penetrating injury in the central cornea did not stimulate nor inhibit cell proliferation of corneal epithelium. The number of BrdU–labeled corneal epithelial cells was statistically significantly less in Fgf2–/– mice than in Fgf2+/+ mice in both uninjured, and injured, conditions. There was no difference in number of cells undergoing apoptosis of epithelial cells between both groups as determined by TUNEL. In vitro studies showed that addition of 5.0 ng/ml FGF2 enhanced proliferation of HCECs and this growth–promoting effect was abolished by adding 50 µg/ml PD98059. Conclusions: FGF2 is required to support proliferating activity of corneal epithelium in mice. MAP kinase cascade is involved in FGF2’s cell proliferation–stimulating effect.

Keywords: cornea: epithelium • growth factors/growth factor receptors • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×